Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level

Journal of Periodontology

Volumn 82, Issue 5, 2011, Pages 716-725

  Buduneli, Eralp ^a   Mäntylä, Päivi ^b   Emingil, Gülnur ^a   Tervahartiala, Taina ^b   Pussinen, Pirkko ^b   Bariş, Nezihi ^c   Akilli, Azem ^a   Atilla, Gül ^a   Sorsa, Timo ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF HELSINKI   (Finland)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Matrix metalloproteinases; Myocardial infarction; Pathogenesis; Periodontal disease; Saliva; Serum

Indexed keywords

BIOLOGICAL MARKER; COLLAGENASE 3; GELATINASE B; MATRILYSIN; MMP13 PROTEIN, HUMAN; MMP7 PROTEIN, HUMAN; MMP8 PROTEIN, HUMAN; NEUTROPHIL COLLAGENASE; SALIVA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTITIS; SALIVA; WESTERN BLOTTING;

ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHRONIC PERIODONTITIS; FEMALE; GINGIVAL HEMORRHAGE; GINGIVITIS; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 79955659478     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100492     Document Type: Article

References (55)

1. Reddy SG, Roberts WC. Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of coronary care units. Am J Cardiol 1989;63:906-911. (Pubitemid 19105123)
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
3. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-781. (Pubitemid 19084520)
4. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993;103:205-211. (Pubitemid 23360934)
5. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67(Suppl. 10):1123-1137. (Pubitemid 126613093)
6. Emingil G, Buduneli E, Aliyev A, Akilli A, Atilla G. Association between periodontal disease and acute myocardial infarction. J Periodontol 2000;71:1882-1886. (Pubitemid 33601025)
7. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
8. Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321. (Pubitemid 44385100)
9. Ingman T, Tervahartiala T, Ding Y, et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996;23:1127-1132. (Pubitemid 126732090)
10. Chen HY, Cox SW, Eley BM, Mäntylä P, Rönkä H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000;27:366-369.
11. Westerlund U, Ingman T, Lukinmaa PL, et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996;75:1553-1563. (Pubitemid 32770461)
12. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7:423-432. (Pubitemid 30027564)
13. Parks WC, López-Boado YS, Wilson CL. Matrilysin in epithelial repair and defense. Chest 2001;120(Suppl. 1):36S-41S. (Pubitemid 32702133)
14. López-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 2000;148:1305-1315.
15. Tervahartiala T, Pirilä E, Ceponis A, et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000;79:1969-1977.
16. Kivelä-Rajamäki M, Maisi P, Srinivas R, et al. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 2003;38:583-590. (Pubitemid 37494408)
17. Emingil G, Tervahartiala T, Mãntylã P, Määttä M, Sorsa T, Atilla G. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease. J Periodontol 2006;77:2040-2050. (Pubitemid 46002084)
18. Reynolds JJ, Meikle MC. The functional balance of metalloproteinases and inhibitors in tissue degradation: Relevance to oral pathologies. J R Coll Surg Edinb 1997;42:154-160. (Pubitemid 27259559)
19. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003;92:827-839. (Pubitemid 36542523)
20. Meikle MC, Hembry RM, Holley J, Horton C, McFarlane CG, Reynolds JJ. Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodontal Res 1994;29:118-126.
21. Nomura T, Ishii A, Oishi Y, Kohma H, Hara K. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: The relevance to periodontal diseases. Oral Dis 1998;4:231-240. (Pubitemid 29011529)
22. Kubota T, Nomura T, Takahashi T, Hara K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol 1996;41:253-262. (Pubitemid 126652118)
23. Udall JN, Bloch KJ, Vachino G, Feldman P, Walker WA. Development of the gastrointestinal mucosal barrier. IV. The effect of inhibition of proteolysis on the uptake of macromolecules by the intestine of the newborn rabbit before and after weaning. Biol Neonate 1984;45:289-295. (Pubitemid 14144888)
24. Li YY, McTiernan CF, Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 2000;46:214-224. (Pubitemid 30204593)
25. Peterson JT, Hallak H, Johnson L, et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 2001;103:2303-2309. (Pubitemid 32433722)
26. Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998;32:368-372. (Pubitemid 28396484)
27. Hojo Y, Ikeda U, Ueno S, Arakawa H, Shimada K. Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn Circ J 2001;65:71-75.
28. Eckart RE, Uyehara CF, Shry EA, Furgerson JL, Krasuski RA. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization. J Interv Cardiol 2004;17:27-31. (Pubitemid 38326510)
29. Tziakas DN, Chalikias GK, Parissis JT, et al. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. Int J Cardiol 2004;94:269-277. (Pubitemid 38490672)
30. Kato R, Momiyama Y, Ohmori R, Taniguchi H, Nakamura H, Ohsuzu F. Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease. Circ J 2005;69:1035-1040. (Pubitemid 41603087)
31. Cavusoglu E, Ruwende C, Chopra V, et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 2006;151:1101.e1-1101. e8.
32. Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006;12:66-72. (Pubitemid 43267754)
33. Fukuda D, Shimada K, Tanaka A, et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006;97:175-180. (Pubitemid 43139231)
34. Furuholm J, Sorsa T, Qvarnström M, et al. Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease. J Periodontal Res 2006;41:486-489. (Pubitemid 44337264)
35. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
36. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504-31509. (Pubitemid 28013291)
37. Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis 2010;16:39-45.
38. Leppilahti JM, Ahonen MM, Hernández M, et al. Oral rinse MMP-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden. Oral Dis 2011;17:115-122.
39. Hemmilä I, Dakubu S, Mukkala VM, Siitari H, Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137:335-343.
40. Lauhio A, Salo T, Ding Y, et al. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and nonsteroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol 1994;98:21-28. (Pubitemid 24315446)
41. Kiili M, Cox SW, Chen HY, et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: Molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002;29:224-232. (Pubitemid 41697858)
42. Lauhio A, Sorsa T, Srinivas R, et al. Urinary matrix metalloproteinase-8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy. Ann Med 2008;40:312-320. (Pubitemid 351563934)
43. Rautelin HI, Oksanen AM, Veijola LI, et al. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis. Ann Med 2009;41:208-215.
44. Tuomainen AM, Nyyssönen K, Laukkanen JA, et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 2007;27:2722-2728. (Pubitemid 350158928)
45. Söder B. Neutrophil elastase activity, levels of prostaglandin E2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers. Acta Odontol Scand 1999;57:77-82.
46. Söder B, Jin LJ, Wickholm S. Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002;29:384-391. (Pubitemid 41697824)
47. Mäntylä P, Stenman M, Kinane D, et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res 2006;41:503-512. (Pubitemid 44656925)
48. Mäntylä P, Stenman M, Kinane DF, et al. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res 2003;38:436-439. (Pubitemid 37465553)
49. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ Res 2001;89:201-210. (Pubitemid 34132679)
50. Herzog E, Gu A, Kohmoto T, Burkhoff D, Hochman JS. Early activation of metalloproteinases after experimental myocardial infarction occurs in infarct and noninfarct zones. Cardiovasc Pathol 1998;7:307-312. (Pubitemid 28539670)
51. van den Borne SW, Cleutjens JP, Hanemaaijer R, et al. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 2009;18:37-43.
52. Yamamoto D, Takai S. Pharmacological implications of MMP-9 inhibition by ACE inhibitors. Curr Med Chem 2009;16:1349-1354.
53. Rugina M, Caras I, Jurcut R, et al. Systemic inflammatory markers in patients with aortic sclerosis. Roum Arch Microbiol Immunol 2007;66:10-16.
54. Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142. (Pubitemid 29474417)
55. Ducharme A, Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000;106:55-62. (Pubitemid 30437240)